BSE Live
Dec 10, 16:01Prev. Close
749.05
Open Price
761.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:56Prev. Close
758.00
Open Price
750.00
Bid Price (Qty.)
795.85 (295)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 69.16 | 46.65 | 40.33 | 44.67 | 17.62 | |
| Net CashFlow From Operating Activities | 83.10 | 35.38 | 28.05 | 40.90 | 132.67 | |
| Net Cash Used In Investing Activities | -76.20 | -6.94 | -50.81 | -16.65 | 55.65 | |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | 0.00 | -9.13 | -161.88 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 6.90 | 28.44 | -22.76 | 15.12 | 26.45 | |
| Cash And Cash Equivalents Begin of Year | 48.51 | 20.07 | 42.83 | 27.70 | 1.26 | |
| Cash And Cash Equivalents End Of Year | 55.41 | 48.51 | 20.07 | 42.83 | 27.70 |
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y